Fertiglobe (FERTIGLB) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
29 Apr, 2026Executive summary
Q1 2026 revenue rose 32% year-over-year to $915 million, with adjusted EBITDA up 31% to $342 million and adjusted net profit nearly doubling to $145 million, reflecting strong operational and financial resilience amid challenging geopolitical conditions.
Urea operating rates reached 96% in Q1 2026, with Egyptian operations exceeding 105% and no downtime, driven by operational improvements.
Own-produced sales volumes declined 12% year-over-year due to trade disruptions and prior year base effect; normalized, volumes would be up 5%.
Tight global supply and strong seasonal demand offset lower volumes, supporting robust financial results.
ADNOC completed acquisition of a majority stake, now holding 87.4% of shares, and board composition was updated.
Financial highlights
Revenue reached $915 million, up 32% year-over-year and 13% sequentially from Q4 2025.
Adjusted EBITDA was $342 million, up 31% year-over-year, with a margin of 37.4%.
Adjusted net profit attributable to shareholders was $145 million, nearly doubling year-over-year.
Reported net profit was $198 million, including a one-off non-cash tax gain of $52.7 million.
Free cash flow before growth CapEx was $235 million, up 10% year-over-year.
Net debt as of March 31, 2026, was $822 million, with net debt to adjusted EBITDA at 0.7x, down from $1.006 billion at year-end 2025.
Total assets grew to $5.2 billion as of March 31, 2026.
Outlook and guidance
Near-term market fundamentals remain robust due to tight supply and in-season demand; normalization of pricing will be gradual as trade routes reopen.
Maintenance CapEx guidance for 2024–2026 remains $145–$170 million per year, normalizing to $105–$125 million from 2027.
Dividend policy remains to distribute substantially all excess free cash flow after growth and maintaining investment grade.
Urea market expected to remain tight with a supply deficit of ~2.1 Mt in 2026–30; most new capacity additions post-2027/28.
Low-carbon ammonia demand expected to accelerate post-2030, driven by regulatory and multisector growth.
Latest events from Fertiglobe
- 2025 saw record growth in revenue, EBITDA, and shareholder returns amid tight nitrogen markets.FERTIGLB
Q4 202511 Feb 2026 - Lower H1 2024 earnings amid market headwinds, but cash flow and low-carbon projects advanced.FERTIGLB
Q2 20242 Feb 2026 - Q3 revenue and profit fell, but ADNOC's project transfers will double ammonia capacity by 2029.FERTIGLB
Q3 202415 Jan 2026 - 2024 profit fell, but cost savings and shipment deferrals set up a stronger 2025.FERTIGLB
Q4 202429 Dec 2025 - Revenue and EBITDA grew in Q2 and H1 2025, with ADNOC now the controlling shareholder.FERTIGLB
Q2 202523 Nov 2025 - Q1 2025 revenue up 26%, EBITDA up 45%, ADNOC holds 86.2%, $1B+ EBITDA 2030 targeted.FERTIGLB
Q1 2025 & CMD20 Nov 2025 - Q3 2025 saw strong revenue, EBITDA, and profit growth, with robust capital returns and outlook.FERTIGLB
Q3 202510 Nov 2025